What is the elimination half‑life of tadalafil?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tadalafil Half-Life

The elimination half-life of tadalafil is 17.5 hours. 1, 2

Pharmacokinetic Profile

  • Tadalafil has a mean terminal half-life of 17.5 hours in healthy subjects, with a mean oral clearance of 2.5 L/hr 2
  • This long half-life distinguishes tadalafil from other phosphodiesterase type 5 (PDE5) inhibitors like sildenafil and vardenafil, which have half-lives of approximately 4 hours 1
  • The extended half-life enables therapeutic plasma concentrations to be sustained for up to 36 hours after a single dose 3, 4, 5

Clinical Implications of the 17.5-Hour Half-Life

Nitrate Interaction Window

  • Patients taking tadalafil must avoid nitroglycerine for at least 48 hours after the last dose due to the risk of severe hypotension 1
  • This is a longer contraindication period compared to sildenafil or vardenafil (24 hours), directly reflecting tadalafil's longer half-life 1
  • The combination of tadalafil with nitrate medications is absolutely contraindicated in patients with chronic coronary disease 1

Dosing Flexibility

  • The 17.5-hour half-life makes tadalafil suitable for both on-demand dosing and once-daily continuous therapy 4, 6
  • With once-daily dosing, steady-state plasma concentrations are achieved within 5 days, with exposure approximately 1.6-fold greater than after a single dose 2
  • Maximum plasma concentration (Cmax) occurs between 30 minutes and 6 hours after administration (median 2 hours) 2

Special Populations

  • Elderly patients (≥65 years) have 25% higher tadalafil exposure (AUC) due to lower oral clearance, though no dose adjustment is routinely required based on age alone 2
  • Patients with diabetes mellitus show approximately 19% reduced exposure with no clinically significant impact on efficacy 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.